?ou'd think that if TIS had any interest in raising their share...

?ou'd think that if TIS had any interest in raising their share price that they would comment on the after care of the original trial patients. I realise that that may not be official reporting, but I'm sure there are a lot like me who want to know about "Then what happened". Its easy for them to find out. Pretty difficult for shareholders. Maybe easy for big pharmas ?
Yes I've been nibbling, too. I'd go harder if I knew wot append next.
Japes